Disabling an oncogenic transcription factor by targeting of control kinases
Oncotarget
.
2018 Aug 17;9(64):32276-32277.
doi: 10.18632/oncotarget.25971.
Authors
Christopher R Vakoc
1
,
Alex Kentsis
2
Affiliations
1
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
2
Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
PMID:
30190784
PMCID:
PMC6122356
DOI:
10.18632/oncotarget.25971
No abstract available
Keywords:
kinase; leukemia; therapy; transcription factor.
Publication types
Editorial
Grants and funding
R01 CA204396/CA/NCI NIH HHS/United States